Shivtek Spechemi Industries Ltd, a specialty chemicals manufacturer and the flagship company of the Shiva Group of Industries, announced the appointment of Dr. Trusar D. Bagul as an Independent Director on its board. The strategic move underscores Shivtek’s focus on strengthening governance, technical leadership and innovation-led growth.
Strengthening Scientific and Governance Capabilities
Dr. Bagul brings a rare blend of deep academic research and extensive industrial experience. Through this appointment, Shivtek aims to enhance scientific governance and informed decision-making as it advances its long-term expansion and innovation roadmap.
Nearly Three Decades of Scientific and Industry Experience
With close to three decades of experience across drug discovery, pharmaceuticals, fine chemicals and specialty chemicals, Dr. Bagul combines strong scientific acumen with business and operational insight. A prolific researcher, he has authored multiple international publications and holds several U.S. and Indian patents. Importantly, he has led research and operations teams in translating complex synthetic chemistry into commercially viable solutions. His expertise in high-value, low-volume projects and cost-effective chemical development will play a pivotal role in Shivtek’s upcoming R&D initiatives.
Management Perspective on the Appointment
Amitt Nenwani, Managing Director, Shivtek Spechemi Industries Ltd, said, “We are delighted to welcome Dr. Trusar D. Bagul to our Board. As Shivtek embarks on an expansion journey focused on strengthening India’s self-reliance in the chemical sector through green manufacturing and advanced import-substitution products, his profound expertise and scientific guidance will be invaluable. This appointment reinforces our commitment to strong governance and informed leadership.”
Role as Independent Director
As an Independent Director, Dr. Bagul will work closely with Shivtek’s research and development teams, providing deep technical oversight as the company navigates increasingly complex and technology-driven expansions. His role strengthens strategic alignment between innovation, sustainability, and commercial execution.
Dr. Bagul’s Vision for Shivtek
Dr. Trusar D. Bagul said, “I am pleased to join Shivtek Spechemi Industries Ltd at a pivotal stage of its growth. The company’s commitment to sustainability, quality and global expansion resonates strongly with my professional values. I look forward to working with the Board and management to support strategic priorities and help position Shivtek as a global hub for green specialty chemistry.”
Global Research Exposure and Advisory Experience
An accomplished organic and medicinal chemist, Dr. Bagul has held senior leadership roles across chemistry-focused enterprises, working closely with global pharmaceutical and biotechnology clients. He is also an entrepreneur and currently provides scientific and strategic advisory services to pharma, biopharma and chemical companies.
As per the press release, earlier in his career, Dr. Bagul completed post-doctoral research at Kyoto University, Japan. His work was published in reputed international journals. He is a recipient of prestigious fellowships, including the Japan Society for the Promotion of Science (JSPS) fellowship. This further highlights his global scientific credentials.
